Schizophrenia, tardive dyskinesia, and a D3 receptor gene variant: a new twist on dyskinesias?
Jeste
D V
DV
Kelsoe
J R
JR
D014150:Antipsychotic Agents / Q000009:adverse effects; D004198:Disease Susceptibility; D004200:Diseases in Twins; D018492:Dopamine Antagonists / Q000009:adverse effects; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology / Q000209:etiology / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D017448:Receptors, Dopamine D2 / Q000172:deficiency / Q000235:genetics* / Q000502:physiology; D050637:Receptors, Dopamine D3; D012559:Schizophrenia / Q000235:genetics* / Q000503:physiopathology
D014150:Antipsychotic Agents; C493593:DRD3 protein, human; D018492:Dopamine Antagonists; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3